Bridging the gap of vision restoration

被引:0
作者
Carleton, Maya [1 ]
Oesch, Nicholas W. [1 ,2 ,3 ]
机构
[1] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA 92093 USA
关键词
vision restoration; retinal degeneration; age related macular degeneration; retinitis pigmentosa; retinal prosthesis; retina; optogenetics; AGE-RELATED MACULOPATHY; COMPLEMENT FACTOR-H; RD10 MOUSE MODEL; MACULAR DEGENERATION; RETINITIS-PIGMENTOSA; OXIDATIVE STRESS; RETINAL DEGENERATION; CARDIOVASCULAR-DISEASE; GLOBAL PREVALENCE; VISUAL FUNCTION;
D O I
10.3389/fncel.2024.1502473
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Retinitis pigmentosa (RP) and Age-Related Macular Degeneration (AMD) are similar in that both result in photoreceptor degeneration leading to permanent progressive vision loss. This affords the possibility of implementing vision restoration techniques, where light signaling is restored to spared retinal circuitry to recreate vision. There are far more AMD patients (Wong et al., 2014), yet more resources have been put towards researching and developing vision restoration strategies for RP despite it rarity, because of the tractability of RP disease models. The hope is that these therapies will extend to the AMD population, however, many questions remain about how the implementation of prosthetic or optogenetic vision restoration technologies will translate between RP and AMD patients. In this review, we discuss the difference and similarities of RP and AMD with a focus on aspects expected to impact vision restoration strategies, and we identify key gaps in knowledge needed to further improve vision restoration technologies for a broad patient population.
引用
收藏
页数:14
相关论文
共 149 条
  • [31] Bardet-Biedl syndrome
    Forsythe, Elizabeth
    Beales, Philip L.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2013, 21 (01) : 8 - 13
  • [32] Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
    Foss, Alexander
    Rotsos, Tryfon
    Empeslidis, Theo
    Chong, Victor
    [J]. OPHTHALMOLOGICA, 2022, 245 (03) : 204 - 217
  • [33] Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
  • [34] Racial differences in the prevalence of age-related macular degeneration - The Baltimore eye survey
    Friedman, DS
    Katz, J
    Bressler, NM
    Rahmani, B
    Tielsch, JM
    [J]. OPHTHALMOLOGY, 1999, 106 (06) : 1049 - 1055
  • [35] Systematic review and meta-synthesis of coping with retinitis pigmentosa: implications for improving quality of life
    Garip, Gulcan
    Kamal, Atiya
    [J]. BMC OPHTHALMOLOGY, 2019, 19 (01)
  • [36] Muller Glia Reactivity and Development of Gliosis in Response to Pathological Conditions
    Graca, Anna B.
    Hippert, Claire
    Pearson, Rachael A.
    [J]. RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2018, 1074 : 303 - 308
  • [37] Microglia: biology and pathology
    Graeber, Manuel B.
    Streit, Wolfgang J.
    [J]. ACTA NEUROPATHOLOGICA, 2010, 119 (01) : 89 - 105
  • [38] Patterns of visual field progression in patients with retinitis pigmentosa
    Grover, S
    Fishman, GA
    Brown, J
    [J]. OPHTHALMOLOGY, 1998, 105 (06) : 1069 - 1075
  • [39] Rescuing cones and daylight vision in retinitis pigmentosa mice
    Guadagni, Viviana
    Biagioni, Martina
    Novelli, Elena
    Aretini, Paolo
    Mazzanti, Chiara Maria
    Strettoi, Enrica
    [J]. FASEB JOURNAL, 2019, 33 (09) : 10177 - 10192
  • [40] Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration
    Gupta, N
    Brown, KE
    Milam, AH
    [J]. EXPERIMENTAL EYE RESEARCH, 2003, 76 (04) : 463 - 471